Nova Leap Health Corp. NLH.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 234.30% | 514.56% | -106.06% | 305.00% | -313.22% |
| Total Depreciation and Amortization | -14.41% | -24.39% | 30.73% | 59.64% | 50.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -96.92% | -203.02% | 137.51% | -126.62% | 2,306.78% |
| Change in Net Operating Assets | -26.13% | -174.17% | -249.01% | -389.84% | 23.85% |
| Cash from Operations | 48.31% | 101.32% | -18.28% | 63.91% | 57.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -728.15% | -- | 100.00% | -- | -11.96% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -728.15% | -- | 100.00% | -- | -11.96% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -18.22% | -27.58% | -29.05% | -164.92% | -176.57% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 17.77% | 11.48% | -426.83% | -- | -- |
| Cash from Financing | 526.17% | -140.44% | -134.74% | -210.46% | -225.08% |
| Foreign Exchange rate Adjustments | -130.49% | -900.00% | 180.25% | -7,600.00% | 1,492.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -371.59% | 260.98% | -288.52% | -8.79% | 23.87% |